Avricore Health (AVCRF) Equity Average (2014 - 2021)

Avricore Health (AVCRF) reported Equity Average of $1.8 million for Q4 2021, down 4.65% quarter-over-quarter from $1.9 million in Q3 2021.

Avricore Health (AVCRF) Equity Average (2014 - 2021) Analysis & Trends

Avricore Health (AVCRF) has 3 years of Equity Average data on file, last reported at $1.8 million in Q4 2021.

Equity Average for Q4 2021 came in at $1.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $1.8 million (changed N/A YoY), and the FY2023 annual result was $1.5 million, down 8.09% from the prior year.
Equity Average slipped to $1.8 million in Q4 2021 per AVCRF's latest filing, from $1.9 million in the prior quarter.
Over five years, Equity Average peaked at $2.0 million in Q2 2021 and troughed at -$247349.8 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn	8.93 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn	52.67 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn	52.75 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn	1.58 Bn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn	3.35 Bn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn	1.74 Bn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn	6.49 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn	2.70 Bn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn	-32.76 Mn
10	Avricore Health	-	-	-	-

Download Data